Viewing StudyNCT00002560



Ignite Creation Date: 2024-05-05 @ 11:08 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002560
Status: COMPLETED
Last Update Posted: 2013-06-28
First Post: 1999-11-01

Brief Title: Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Neuroblastoma
Keywords:
Name View
recurrent neuroblastoma View